About this page
GENB — Generate Biomedicines
Why Generate Biomedicines (GENB) moved: the last session's move split into the market, its industry, its themes and the part unique to the company, with our latest explained moves and their sources, beside the live chart.
On Friday, November 20, 2026, Generate Biomedicines (GENB) fell 8.00% at the close. Where it came from: Market (SPY) -6.90%, Biotechnology +1.96%, Factors (6) +0.35%, Unique to GENB -3.41%.
Fell with the market: chipmakers led it lower on Anthropic headlines (Yahoo). The stories that moved the market.
Generate Biomedicines (GENB) last reported earnings on Thursday, November 12, 2026, before the open (SEC 8-K); that session, GENB fell 6.82% at the close — why GENB moved on Nov 12, 2026. The earnings calendar.
Explained moves for GENB:
- Thursday, November 12, 2026: GENB fell 6.8% after Q3 results missed estimates on EPS and sales (sec.gov, Benzinga)
Each explained move has its own page: Thursday, November 12, 2026.
Only on this page: GENB's split updating every minute while the market is open, which of the 6 factors moved it and by how much, and the catalyst behind its explained move, with sources.
Explore daily moves on this page shows where GENB's moves came from, session by session — the market, its industry, its themes, its factors and its own part. The month and three-month views are free; six months, the year to date and the full year, with every day's breakdown and its full explanation, are part of TickerTiles Plus.
All stocks: Why stocks moved. The whole market: Market Overview.